PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 15, 2002 Subscribe to this News Feed    
 

Promatrix® announces its first U.S. product launch with a breakthrough patent pending hormonal dietary supplement Primobolan® Acetate orals.

Promatrix® announces its first U.S. product launch with a breakthrough patent pending hormonal dietary supplement Primobolan® Acetate orals. Primobolan® Acetate is a hormonal analog of a naturally occurring substance found in the human body. It is designed to inhibit estrogen formation while simultaneously promoting the natural production of total and active testosterone. This new patent pending compound is truly an essential supplement for anyone concerned with physique, strength, recovery and libido enhancements.

For immediate release"
Promatrix® announces its first U.S. product launch with a breakthrough patent pending hormonal dietary supplement Primobolan® Acetate orals.
Promatrix® is a leading biotechnology company in the field of the metabolic nutrition associated with hormonal response and human performance, which is dedicated to develop, manufacture, and market approved and clinically effective nutraceuticals that address significant human performance needs.
We are extremely optimistic that Promatrix® will become a predominant entity in the sports supplement market. We feel this way not only because of Primobolan® but because of our dedication to nutraceutical research," said Sal Abraham M.S. R.D., Dir. of Research & Patent Development.
Primobolan® Acetate is a hormonal analog of a naturally occurring substance found in the human body. It is designed to inhibit estrogen formation while simultaneously promoting the natural production of total and active testosterone. Primobolan® Acetate primarily functions as an aromatase inhibitor thus inhibiting estrogen formation and stimulating natural testosterone production. The stimulation of total and free testosterone promotes muscle mass, strength, and recovery while the inhibition of estrogen may contribute to fat loss and muscle hardening.
Individuals who can benefit from this compound include anyone interested in altering their physique and athletic performance. This compound may also be utilized by pro-hormone or non pro-hormone users. This new patent pending compound is truly an essential supplement for anyone concerned with physique, strength, recovery and libido enhancements.
    
Sal Abraham M.S. R.D.
Dir. of Research & Patent Development
200 N. Church Rd.
Franklin, NJ 07416
Email: info@Primobolan.com
Web site: http://www.Primobolan.com
Phone: 1-877-628-7499
05/08/02
001

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Sal Abraham M.S. R.D.
Promatrix
1-877-628-7499
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.